期刊
BIOMARKERS IN MEDICINE
卷 10, 期 12, 页码 1269-1285出版社
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2016-0192
关键词
cancer; circulating tumor cells (CTCs); precision therapy; predictive marker; prognostic marker
资金
- Department of Defense
- Prostate Cancer Foundation
- NIH [T32G007753]
The rapidly growing array of therapeutic options in cancer requires informative biomarkers to guide the rational selection and precision application of appropriate therapies. Circulating biomarkers such as circulating tumor cells have immense potential as noninvasive, serial 'liquid biopsies' that may be more representative of the complete spectrum of a patient's individual malignancy than spatially and temporally restricted tumor biopsies. In this review, we discuss the current state-of-the-art in the isolation and molecular characterization of circulating tumor cells as well as their utility in a wide range of clinical applications such as prognostics, treatment monitoring and identification of novel therapeutic targets and resistance mechanisms to enable real-time adjustments in the clinical management of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据